Table 5.
PC1 | PC2 | ||
---|---|---|---|
P_AEA | 0.13562 | F_pea | 0.148486 |
P_AA | 0.128696 | L_dhea | 0.141097 |
P_DLE | 0.12706 | F_TBXB3 | 0.138751 |
L_13,14-dihydro-15-keto-PGF2a | 0.120315 | P_DHEA | 0.137637 |
L_AA | 0.12015 | P_19,20-DiHoPE | 0.137193 |
L_2-ag | 0.116734 | F_UK3 | 0.136532 |
P_11,12-DiHETrE | 0.116219 | F_5(S)-HETE | 0.136382 |
L_8,9-DiHETrE | 0.115152 | F_17 keto- 4(z), 7(z), 10(z), 13 (z), 15 (E), 19(z)-DHA | 0.135592 |
I_13,14-dihydro-15-keto-PGE2 | 0.114106 | F_PGE3 | 0.133149 |
I_2-ag | 0.113331 | F_19,20-DiHoPE | 0.133074 |
L_15(S)-HETE | 0.112971 | F_oea | 0.132124 |
F_aea | 0.112488 | F_UK5 | 0.131976 |
L_EPA | −0.11245 | F_UK2 | 0.128994 |
L_14,15 EET | 0.111192 | I_PGE3 | 0.128277 |
L_5(S)-HEPE | −0.11066 | F_UK4 | 0.127957 |
L_11(S)-HETE | 0.10907 | P_DHA | 0.127188 |
P_14,15-DiHETrE | 0.107335 | F_AA | 0.125684 |
I_13,14-dihydro-15-keto-PGF2a | 0.105203 | F_5(S)-HEPE | 0.12297 |
P_8,9-DiHETrE | 0.104781 | I_19,20-DiHoPE | 0.121367 |
L_11,12 EET | 0.103724 | F_12,13-DiHOME | 0.12071 |
I_13,14-dihydro-15-keto-PGD2 | 0.100174 | P_PEA | 0.120517 |
L_PGE2 | 0.100147 | P_12,13-DiHOME | 0.118135 |
I_12(S)-HEPE | −0.09961 | F_lipoxin A4 | 0.115389 |
F_2-ag | 0.099293 | P_EPEA | 0.115294 |
L_14,15-DiHETrE | 0.098683 | F_5,6 EET | 0.115132 |
L_12(S)-HHTrE | 0.098509 | F_PGD3 | 0.114641 |
I_EPA | −0.09806 | F_dhea | 0.113431 |
F_dle | 0.09791 | L_epea | 0.112967 |
F_13,14-dihydro-15-keto-PGF2a | 0.097779 | P_9,10-DiHOME | 0.11289 |
F_EPA | −0.09662 | F_9,10-DiHOME | 0.109149 |
The D-scores represent the variable’s weight in the separation, and is expressed as the numerical output value as obtained from the PCA model; the further away from zero, the better this variable accounts for group separation. PC1 separated the diets, whereas PC2 separated between saline and LPS treatment
P plasma, L liver, I ileum, F adipose tissue